Qatawneh MA, Altarawneh M, Alhazaimeh R, Jazazi M, Jarrah O, Shorman A, Alsadah L, Mustafa M. Manifestations of COVID-19 infection in children with malignancy: A single-center experience in Jordan. World J Virol 2022; 11(5): 321-330 [PMID: 36188736 DOI: 10.5501/wjv.v11.i5.321]
Corresponding Author of This Article
Mousa Ahmad Qatawneh, MD, Consultant Physician-Scientist, Staff Physician, Department of Hematology and Medical Oncology and Stem Cell Transplantation Unit, Queen Rania Children’s Hospital, Royal Medical Services, Dabouq, Amman 11183, Jordan. dr_m_qatawneh@yahoo.com
Research Domain of This Article
Oncology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Symptoms that did not require hospital admission; if hospitalization was required, the indication was for a cause other than the management of COVID-19 associated symptoms or signs
Moderate disease
Symptoms that required inpatient management of COVID-19 associated symptoms, but without the need for PICU care
Severe disease
Symptoms that required PICU care for COVID-19 related signs and symptoms
Table 2 Characteristics of pediatric oncology patients with coronavirus disease 2019
Patient characteristics
Number
Percentage (%)
Sex
Male
24
60
Female
16
40
Age
1-6 yr
28
70
6-12 yr
5
12.5
12-14 yr
7
17.5
Primary disease
Acute lymphoblastic leukemia
30
75
Acute myeloid leukemia
2
5
Neuroblastoma
2
5
Rhabdomyosarcoma
2
5
CNS tumors
2
5
Hodgkin lymphoma
2
5
Table 3 Laboratory and radiological details for coronavirus disease 2019 in our oncology patients
Parameters
Numbers
Percentage (%)
WBC count
Leukopenia < 4000
16
40
Normal WBC count
20
50
Leukocytosis > 16000
4
10
Lymphocytes count
Lymphopenia
23
57.5
Normal count
17
42.5
Lymphocytosis
0
0
Neutrophil count
Severe neutropenia
10
25
Mild-Moderate neutropenia
10
25
Normal count
16
40
Neutrophilia
4
10
CRP titer
Negative < 6
3
7.5
Positive 6
37
92.5
D-Dimer
Positive
6
15
Negative
34
85
IgG level
< 700 mg/dL
9
22.5
> 700 mg/dL
31
77.5
Chest X-ray findings
Normal chest X-ray
18
45
Perihilar infiltrates
12
30
Bilateral patchy consolidation
10
25
High-resolution chest CT scan findings
Bilateral infiltration > 25%
8
20
Bilateral infiltration 25%-50%
2
5
Bilateral infiltration > 50%
0
0
Table 4 Details of the clinical course of coronavirus disease 2019 in oncology patients
Parameters
Number
Percentage
Presenting symptoms
Fever
24
60
Cough
15
37.5
Sore throat
3
7.5
Dyspnea
2
5
Diarrhea
2
5
Disease severity
Asymptomatic
10
25
Mild disease
20
50
Moderate disease
8
20
Severe disease
2
5
Place of care
Home isolation
12
30
COVID-19 ward
26
65
PICU
2
5
Treatment required
No treatment
10
25
IV antibiotic
24
60
Azithromycin
30
75
Vitamins
30
75
Dexamethasone
26
65
Oxygen support
4
10
CPAP
2
5
IVIG
9
22.5
Citation: Qatawneh MA, Altarawneh M, Alhazaimeh R, Jazazi M, Jarrah O, Shorman A, Alsadah L, Mustafa M. Manifestations of COVID-19 infection in children with malignancy: A single-center experience in Jordan. World J Virol 2022; 11(5): 321-330